UMIN000047162Not yet recruiting
Investigation of biomarkers to predict immune-related adverse events in patients with non-small cell lung cancer
Kobe UniversityUniversity Hospital Medical Information Network
VerifiedUniversity Hospital Medical Information Network
Study focus
- Disease/Condition
- Non-small cell lung cancer
- Study type
- Observational
Sponsor & location
- Primary sponsor
- Kobe University
- Location
- Japan
Timeline & enrollment
- Phase
- N/A
- Start date
- May 01, 2022
- End date
- N/A
ICD-10 classifications
Secondary malignant neoplasm of lungMalignant neoplasm: Lower lobe, bronchus or lungMalignant neoplasm: Middle lobe, bronchus or lungMalignant neoplasm: Bronchus or lung, unspecifiedMalignant neoplasm of bronchus and lung
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000047162
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000047162 through Pure Global AI's free database. This phase not specified trial is sponsored by Kobe University and is currently Not yet recruiting. The study focuses on Non-small cell lung cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.